Could the Senate adopt a “watershed” bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy studying the information at hand to determine how the legislation would impact the leading companies in the sector, but much remains to be seen. According to analysts with SVB Securities, four […]

The post Lilly, AZ, AbbVie, J&J May Be Hit By Medicare Pricing Bill first appeared on World Pharma Today.